Articles in section Research & Development
| << Opinion & Analysis | 476 articles | Royalties >> |
| Pages 1 2 3 4 5 .. 48 | Next >> |
-
Johnson & Johnson Pays Sail Biomedicines US$785M Upfront to Develop In Vivo CAR-T Therapies for Autoimmune Disease
-
Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases
-
AstraZeneca Signs US$1.77 B Renal Disease Licensing Pact with CSPC Pharmaceutical Group
-
Bristol Myers Squibb Signs US$15.2 B Licensing Pact with Hengrui Pharma for Medicines Across Oncology, Haematology, and Immunology
-
Regeneron and Telix Pharmaceuticals Sign US$4.3 B Radiopharmaceutical Oncology Deal
-
Merck & Co. Inks US$2.2 B IBD Target Discovery Collaboration with Quotient Therapeutics
-
Lilly Signs US$8.85 B Oncology and Immunology Partnership with Innovent Biologics
-
AstraZeneca Signs US$18.5 B Licensing Pact with CSPC Pharmaceutical Group for Obesity and Type 2 Diabetes Treatments
-
Lilly Signs US$1.9 B Global Collaboration with Repertoire for Autoimmune Diseases
-
Boehringer Ingelheim and Simcere Forge US$1.26 B Collaboration to Advance Inflammatory Bowel Disease Bispecific Antibody
RSS